Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA-a retrospective, exploratory cohort study.

Bouman, Chantal A M; Tweehuysen, Lieke; Haverkort, Dieneke; van den Ende, Cornelia H; van der Maas, Aatke; den Broeder, Alfons A

Bouman, Chantal A M; Tweehuysen, Lieke; Haverkort, Dieneke; van den Ende, Cornelia H; van der Maas, Aatke; den Broeder, Alfons A.

Affiliation

Bouman CAM; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.
Tweehuysen L; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.
Haverkort D; Department of Rheumatology, Radboudumc, Nijmegen, The Netherlands.
van den Ende CH; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.
van der Maas A; Department of Rheumatology, Radboudumc, Nijmegen, The Netherlands.
den Broeder AA; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.

Rheumatol Adv Pract ; 2(1): rky008, 2018.

Article in En | MEDLINE | ID: mdl-31431957

Key words

abatacept; biologic; discontinuation; dose optimization; dose reduction; rheumatoid arthritis; tapering; tocilizumab; withdrawal

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research Language: En Journal: Rheumatol Adv Pract Year: 2018 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google